New FDA application for wound-care product submitted by Cardium

08/30/2013 | (Boston)

Cardium Therapeutics has filed a new 510(k) clearance application with the FDA for its wound-therapy product called Excellagen. The new submission includes packaging modifications, more specific labeling and research data indicating that the product can boost platelet activation when used in conjunction with platelet-rich plasma therapy.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI